Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Christopher Mazis"'
Autor:
Nicholas Gravbrot, Kacy Gilbert-Gard, Paras Mehta, Yarah Ghotmi, Madhulika Banerjee, Christopher Mazis, Srinath Sundararajan
Publikováno v:
Antibodies, Vol 8, Iss 4, p 51 (2019)
Recently, modulation of immune checkpoints has risen to prominence as a means to treat a number of solid malignancies, given the durable response seen in many patients and improved side effect profile compared to conventional chemotherapeutic agents.
Externí odkaz:
https://doaj.org/article/5299d0ce720f4a0493170e824452d63e
Autor:
Richard J. O'Reilly, Sean M. Devlin, Ioannis Politikos, Molly Maloy, Josel D. Ruiz, Sergio Giralt, Andromachi Scaradavou, Scott T. Avecilla, Esperanza B. Papadopoulos, Roni Tamari, Craig S. Sauter, Maria E. Arcila, Doris M. Ponce, Jonathan Barone, Christopher Mazis, Ann A. Jakubowski, Miguel Perales, Kristine Naputo, Juliet N. Barker, Katherine C. Hsu, Parastoo B. Dahi
Publikováno v:
Leukemia
Double unit cord blood (dCB) transplantation (dCBT) is associated with high engraftment rates but delayed myeloid recovery. We investigated adding haplo-identical CD34+ cells to dCB grafts to facilitate early haplo-identical donor-derived neutrophil
Autor:
Andromachi Scaradavou, Molly Maloy, Kristine Naputo, Ioannis Politikos, Eric Davis, Deborah Wells, Sean M. Devlin, Christopher Mazis, Juliet N. Barker, Melissa Nhaissi
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:734-744
How cord blood (CB) CD34+ cell content and dose and 8-allele HLA match vary by patient ancestry is unknown. We analyzed cell content, dose, and high-resolution HLA-match of units selected for CB transplantation (CBT) by recipient ancestry. Of 544 uni
Autor:
Deborah Wells, Molly Maloy, Christopher Mazis, Andromachi Scaradavou, Sean M. Devlin, Eric Davis, Parastoo B. Dahi, Esperanza B. Papadopoulos, Nancy A. Kernan, Kirsten Boughan, Doris M. Ponce, Kristine Naputo, Sergio Giralt, Melissa Nhaissi, Candice Cooper, Ioannis Politikos, Juliet N. Barker
Publikováno v:
Blood Advances. 3:939-944
Availability of 8/8 HLA-allele matched unrelated donors (URDs) is a barrier for ethnic and racial minorities. We prospectively evaluated receipt of 8/8 HLA-allele matched URD or either 7/8 URD or cord blood (CB) transplants by patient ancestry from 2
Autor:
Maya El Ghouayel, Mohammad Hamidi, Christopher Mazis, Zaid Imam, Mutaz Abbad, Adam Boutall, Marlon Guerrero, Valentine Nfonsam
Publikováno v:
The Journal of surgical research. 273
Preoperative anemia is relatively common in colon cancer patients; however, its impact on short-term surgical outcomes is not well established. The aim of our study was to evaluate short-term surgical outcomes in colon cancer patients with preoperati
Autor:
Eric Davis, Andromachi Scaradavou, Melissa Nhaissi, Juliet N. Barker, Ioannis Politikos, Christopher Mazis, Kelcey Skinner, Kristine Naputo
Publikováno v:
Bone Marrow Transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ead8e45001f5ec3386e97299670a0680
https://europepmc.org/articles/PMC8996756/
https://europepmc.org/articles/PMC8996756/
Autor:
Kristine Naputo, Christopher Mazis, Eric Davis, Miguel-Angel Perales, Andromachi Scaradavou, Brian C. Shaffer, Satyajit Kosuri, Sean M. Devlin, Sergio Giralt, Juliet N. Barker, Jennifer Paulson, Doris M. Ponce, Ann A. Jakubowski, Deborah Wells, Tara Wolff, Melissa Nhaissi, Courtney Byam, Parastoo B. Dahi
Publikováno v:
Biol Blood Marrow Transplant
The availability of cord blood (CB) and haploidentical (haplo) donors in all patient populations is not established. We have investigated the addition of haplo-CD34+ cells to CB grafts (haplo-CBT) to speed myeloid engraftment. Thus, we have prospecti
Autor:
Yarah Ghotmi, Madhulika Banerjee, Paras P. Mehta, Srinath Sundararajan, Kacy Gilbert-Gard, Nicholas Gravbrot, Christopher Mazis
Publikováno v:
Antibodies
Antibodies, Vol 8, Iss 4, p 51 (2019)
Antibodies, Vol 8, Iss 4, p 51 (2019)
Recently, modulation of immune checkpoints has risen to prominence as a means to treat a number of solid malignancies, given the durable response seen in many patients and improved side effect profile compared to conventional chemotherapeutic agents.
Autor:
Hugo Castro-Malaspina, Miguel-Angel Perales, Christina Cho, Kristine Naputo, Aishat Afuye, Marcel R.M. van den Brink, Doris M. Ponce, Andromachi Scaradavou, Richard J. O'Reilly, Roni Tamari, Michael Scordo, Molly Maloy, Esperanza B. Papadopoulos, James W. Young, Juliet N. Barker, Sean M. Devlin, Brian C. Shaffer, Boglarka Gyurkocza, Parastoo B. Dahi, Ioannis Politikos, Scott T. Avecilla, Gunjan L. Shah, Sergio Giralt, Craig S. Sauter, Ann A. Jakubowski, Christopher Mazis
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S208-S209
Background The less stringent CB HLA-match requirement extends allograft access. The extent to which HLA-mismatch can adversely affect CBT outcomes & the maximum permitted HLA-mismatch, however, are not established. Methods We analyzed TRM, relapse &
Autor:
Gunjan L. Shah, Kristine Naputo, Aishat Afuye, Miguel-Angel Perales, Richard J. O'Reilly, James W. Young, Katharine C. Hsu, Doris M. Ponce, Esperanza B. Papadopoulos, Sergio Giralt, Roni Tamari, Ioannis Politikos, Parastoo B. Dahi, Andromachi Scaradavou, Sean M. Devlin, Hugo Castro-Malaspina, Craig S. Sauter, Brian C. Shaffer, Ann A. Jakubowski, Michael Scordo, Boglarka Gyurkocza, Juliet N. Barker, Marcel R.M. van den Brink, Christopher Mazis, Scott T. Avecilla, Christina Cho, Molly Maloy
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S207-S208
Background While dCBT is associated with high rates of sustained donor engraftment, delayed neutrophil recovery is frequent. Methods We investigated the addition of CD34+ selected haplo-identical PBSC to double unit CB grafts (haplo-dCBT) in patients